Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Senior

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Plos One|November 13, 2018
Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cellsAnissa Gamble, Rena Pawlick, Andrew R Pepper, et al.
Canadian Journal of Diabetes|May 14, 2022
Prevalence of Post-Glucose Challenge Hypoglycemia in Adult Patients With Cystic Fibrosis and Relevance to the Risk of Cystic Fibrosis-Related DiabetesAnne Bonhoure, Kathryn J Potter, Quitterie Reynaud, et al.
Canadian Journal of Diabetes|October 13, 2020
Revision of Alberta's Provincial Insulin Pump Therapy Criteria for Adults and Children With Type 1 Diabetes: Process, Rationale and Framework for EvaluationDalal Haddadi, Elizabeth Rosolowsky, Danièle Pacaud, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 25, 2022
Estimation of Early Graft Function Using the BETA-2 Score Following Clinical Islet TransplantationAnna Lam, Richard A Oram, Shareen Forbes, et al.
Islets|February 9, 2016
Islet-after-failed-pancreas and pancreas-after-failed islet transplantation: Two complementary rescue strategies to control diabetesAxel Andres, Scott Livingstone, Tatsuya Kin, et al.
Nature Medicine|February 18, 2026
Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapyJane Speight, Sufyan Hussain, Ananthi Anandhakrishnan, et al.
Paediatric Respiratory Reviews|November 14, 2022
Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gapsBernadette J Prentice, Kathryn J Potter, Adèle Coriati, et al.
Diabetes|March 30, 2004
Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantationEdmond A Ryan, Tami Shandro, Kristy Green, et al.
Diabetes, Obesity & Metabolism|July 14, 2018
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairmentF Javier Escalada, Serge Halimi, Peter A Senior, et al.
Diabetes|April 28, 2004
Prevalence of hepatic steatosis after islet transplantation and its relation to graft functionRavi Bhargava, Peter A Senior, Thomas E Ackerman, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Plos One|November 13, 2018
Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cellsAnissa Gamble, Rena Pawlick, Andrew R Pepper, et al.
Canadian Journal of Diabetes|May 14, 2022
Prevalence of Post-Glucose Challenge Hypoglycemia in Adult Patients With Cystic Fibrosis and Relevance to the Risk of Cystic Fibrosis-Related DiabetesAnne Bonhoure, Kathryn J Potter, Quitterie Reynaud, et al.
Canadian Journal of Diabetes|October 13, 2020
Revision of Alberta's Provincial Insulin Pump Therapy Criteria for Adults and Children With Type 1 Diabetes: Process, Rationale and Framework for EvaluationDalal Haddadi, Elizabeth Rosolowsky, Danièle Pacaud, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 25, 2022
Estimation of Early Graft Function Using the BETA-2 Score Following Clinical Islet TransplantationAnna Lam, Richard A Oram, Shareen Forbes, et al.
Islets|February 9, 2016
Islet-after-failed-pancreas and pancreas-after-failed islet transplantation: Two complementary rescue strategies to control diabetesAxel Andres, Scott Livingstone, Tatsuya Kin, et al.
Nature Medicine|February 18, 2026
Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapyJane Speight, Sufyan Hussain, Ananthi Anandhakrishnan, et al.
Paediatric Respiratory Reviews|November 14, 2022
Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gapsBernadette J Prentice, Kathryn J Potter, Adèle Coriati, et al.
Diabetes|March 30, 2004
Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantationEdmond A Ryan, Tami Shandro, Kristy Green, et al.
Diabetes, Obesity & Metabolism|July 14, 2018
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairmentF Javier Escalada, Serge Halimi, Peter A Senior, et al.
Diabetes|April 28, 2004
Prevalence of hepatic steatosis after islet transplantation and its relation to graft functionRavi Bhargava, Peter A Senior, Thomas E Ackerman, et al.
Pageof 10